Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies-Perspectives from the American Society of Onco-Nephrology (ASON).
Kitchlu A, Silva VTCE, Anand S, Kala J, Abudayyeh A, Inker LA, Rosner MH, Karam S, Gudsoorkar P, Gupta S, Chen S, Klomjit N, Leung N, Milanez T, Motwani SS, Khalid SB, Srinivasan V, Wanchoo R, Beumer JH, Liu G, Tannir NM, Orchanian-Cheff A, Geng Y, Herrmann SM.
Kitchlu A, et al. Among authors: inker la.
Clin J Am Soc Nephrol. 2024 Aug 1;19(8):1073-1077. doi: 10.2215/CJN.0000000000000509. Epub 2024 Jun 7.
Clin J Am Soc Nephrol. 2024.
PMID: 39316409
No abstract available.